Physiological Role
Copper and zinc are two essential trace elements whose intestinal absorption is linked. In the laboratory, zinc causes a protein to appear in the intestinal wall that captures copper, so that a high zinc intake reduces copper bioavailability. The copper-to-zinc ratio quantifies this interdependent relationship. Singular requests it from no laboratory: it is calculated from the two results of your blood panel, whichever matrix was used to measure them.
Copper is a cofactor for ceruloplasmin, involved in iron metabolism. It also activates superoxide dismutase (Cu/Zn-SOD), a key enzyme in antioxidant defence. Zinc participates in over 300 enzymatic reactions. It contributes to the normal function of the immune system and to normal DNA synthesis. Both elements are required for normal SOD function, illustrating their biological complementarity.
The ratio therefore reflects a functional balance. When it rises, oxidative burden tends to increase. When it falls below the optimal zone, copper bioavailability may become insufficient for the enzymatic functions that depend on it.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Biological Significance
A copper-to-zinc ratio within the optimal zone reflects a favourable metallic balance. Both trace elements are present in sufficient quantities to fulfil their respective functions without neutralising each other.
An elevated ratio signals a relative excess of copper over zinc. This situation is frequently associated with chronic low-grade inflammation. In the presence of inflammation, serum copper rises, carried by ceruloplasmin (an acute-phase protein), while serum zinc decreases as it is redistributed to tissues. The serum ratio is therefore sensitive to inflammation: it is interpreted alongside hs-CRP, ideally outside an acute episode.
A low ratio indicates a relative predominance of zinc. This situation is rare: in the reference cohort, fewer than 1% of men fall below the lower bound of the optimal zone. It may reflect an uncompensated zinc intake or a diet low in copper. This side of the ratio remains poorly documented: published cohorts place their reference category there, without measuring its own effects.
Tracking the ratio over time offers a more informative reading than a single measurement. A progressively rising ratio may signal an inflammatory trend or a nutritional imbalance.
Influencing Factors
Inflammation. Any acute or chronic inflammation alters the distribution of copper and zinc in the body. Serum copper rises, mobilised via ceruloplasmin (an acute-phase protein), while serum zinc decreases as it is redistributed to tissues. The serum ratio is therefore directly sensitive to inflammation: it is interpreted alongside hs-CRP, ideally outside an acute episode.
Age. The copper-to-zinc ratio tends to rise with advancing age. Studies observe a progressive increase after 60, linked to both declining zinc and rising copper levels.
Diet. Foods rich in zinc (red meat, seafood, legumes) and copper (liver, dark chocolate, cashews) directly influence the ratio. A vegetarian or vegan diet, often low in bioavailable zinc, may favour an elevated ratio.
Supplementation. Taking zinc without copper lowers the ratio. Conversely, some multivitamin supplements containing copper without adequate zinc may raise it. In the Singular formula, zinc and copper intakes are set from the measured values of those two minerals.
Oral contraceptives. Oestrogens increase hepatic ceruloplasmin synthesis, raising copper levels and therefore the ratio. This effect is well documented and reversible upon discontinuation.
Physical activity. Intense, prolonged exercise mobilises zinc for tissue repair and antioxidant response, which can temporarily lower zinc levels and raise the ratio.
Chronic stress. Cortisol influences the redistribution of trace elements, contributing to a decrease in circulating zinc and a relative rise in copper.
In the Singular Formula
The copper-to-zinc ratio is an index calculated from individual copper and zinc measurements. This calculation highlights a relative imbalance that neither copper nor zinc, taken individually, would reveal: copper within the optimal zone combined with low zinc produces an elevated ratio.
Zinc and copper intakes are set from the values of those two measurements. Copper follows its own reading, from its own value.
Singular also measures other markers of inflammatory status, such as hs-CRP, which helps contextualise an elevated ratio. A higher ratio associated with elevated hs-CRP points towards a systemic inflammatory component.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Malavolta M et al. | 2015 | Review | Mechanisms of Ageing and Development | View on PubMed |
Serum copper to zinc ratio: Relationship with aging and health status Narrative review: an elevated serum copper-to-zinc ratio is found in several age-related conditions. The ratio rises with ageing and reflects the interaction between inflammation and nutritional status. Limitation: a narrative review, measuring no population of its own and publishing neither a sample size nor a cut-off value. | ||||
| Malavolta M et al. | 2010 | Cohort Study | Biogerontology | View on PubMed |
Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population Italian study of 498 older adults and 164 controls aged 20 to 60, with a three-and-a-half-year mortality follow-up conducted in 218 subjects over 70. The ratio is associated with every inflammatory marker studied and with albumin, and it predicts all-cause mortality. Limitation: the measurement is made in plasma, whereas most other work in this body of evidence measures serum, and no cut-off value is published. | ||||
| Laine JT et al. | 2020 | Cohort Study | European Journal of Epidemiology | View on PubMed |
Serum copper-to-zinc-ratio and risk of incident infection in men: the Kuopio Ischaemic Heart Disease Risk Factor Study Finnish cohort of 1,975 men aged 42 to 60, sampled in the morning after twelve hours of fasting and followed for 19.2 years on average. The highest quarter of the ratio records more hospital-treated infections than the lowest quarter, after adjustment for age. Limitation: the association does not remain significant in the fully adjusted model, and the authors conclude that copper alone is a better marker than the ratio. | ||||
| Mezzetti A et al. | 1998 | Observational Study | Free Radical Biology and Medicine | View on PubMed |
Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases Comparison of 224 people in three groups: 81 healthy adults, 81 healthy octogenarians and nonagenarians, and 62 with loss of autonomy. The serum copper-to-zinc ratio correlates with systemic oxidant load in all three groups. In healthy older people the rise is driven by copper values; in the others a low zinc adds to it. Limitation: a single measurement per person, taken at one point in time, with no follow-up. | ||||
| Mocchegiani E et al. | 2012 | Cohort Study | Age | View on PubMed |
Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study) Italian cohort of 346 people aged 80 and over, with 145 deaths in four years. The highest third of the ratio, above 2.08 in men and 2.24 in women, shows higher mortality than the lowest third. Limitations: those two numbers are the tertile bounds of this sample rather than cut-off values; and the observed links with physical function disappear as soon as inflammatory markers enter the model. | ||||
| Kunutsor SK et al. | 2022 | Cohort Study | Nutrition, Metabolism and Cardiovascular Diseases | View on PubMed |
Serum copper-to-zinc ratio is associated with heart failure and improves risk prediction in middle-aged and older Caucasian men: A prospective study Follow-up of 1,866 Finnish men aged 42 to 61 over a median of 26.5 years, with 365 heart failure events. Risk rises linearly with the ratio, by 63% per whole unit, a gap that spans several times the observed spread. Copper alone carries a more marked risk than zinc alone. Limitations: the population is exclusively Finnish and male, and this is the same cohort as the Laine 2020 entry: the two results are not independent. | ||||
| Shen Y et al. | 2024 | Observational Study | Cardiovascular Toxicology | View on PubMed |
Association Between the Copper-to-Zinc Ratio and Cardiovascular Disease Among Chinese Adults: A China Multi-ethnic Cohort (CMEC) Study Chinese multi-ethnic study of 9,878 adults, measured in urine. The highest quarter of the urinary ratio goes together with a lower cardiovascular prevalence, the opposite direction to the serum cohorts. Limitations: prevalence is recorded at the same time as the measurement, which establishes no sequence over time; and a urinary ratio reflects the excretion of both elements rather than their circulating status: it does not compare with the serum values shown here. | ||||
| Kunutsor SK et al. | 2022 | Cohort Study | BioMetals | View on PubMed |
Serum copper-to-zinc ratio and risk of incident pneumonia in caucasian men: a prospective cohort study Follow-up of 2,503 Finnish men over 26.1 years, with 599 pneumonia events. The highest third of the ratio, from 1.28 upwards, shows a higher risk of pneumonia death than the lowest third, and this result persists after accounting for hs-CRP. The correlation between the ratio and hs-CRP is strong in this cohort. Limitations: the population is exclusively Finnish and male, and this is the same cohort as the Laine 2020 and Kunutsor 2022 heart failure entries. | ||||
| Peng KY et al. | 2026 | Cohort Study | Experimental Gerontology | View on PubMed |
Copper-to-zinc ratio predicts incident sarcopenia and adverse health outcomes: Results from I-Lan Longitudinal Aging Study Taiwanese ageing cohort, in 2,015 then 1,474 participants. A higher ratio goes together with higher mortality and with the onset of sarcopenia, the age-related loss of muscle mass and strength. Both associations survive accounting for inflammatory markers, which makes this the best-adjusted result in this body of evidence. Limitation: the associations are expressed per standard deviation of the ratio, a scale specific to this population, and no cut-off value is derived from it. | ||||